Sandia National Laboratories, Livermore, California, United States of America.
PLoS One. 2013 Oct 14;8(10):e77834. doi: 10.1371/journal.pone.0077834. eCollection 2013.
Francisella tularensis is a zoonotic intracellular pathogen that is capable of causing potentially fatal human infections. Like all successful bacterial pathogens, F. tularensis rapidly responds to changes in its environment during infection of host cells, and upon encountering different microenvironments within those cells. This ability to appropriately respond to the challenges of infection requires rapid and global shifts in gene expression patterns. In this study, we use a novel pathogen transcript enrichment strategy and whole transcriptome sequencing (RNA-Seq) to perform a detailed characterization of the rapid and global shifts in F. tularensis LVS gene expression during infection of murine macrophages. We performed differential gene expression analysis on all bacterial genes at two key stages of infection: phagosomal escape, and cytosolic replication. By comparing the F. tularensis transcriptome at these two stages of infection to that of the bacteria grown in culture, we were able to identify sets of genes that are differentially expressed over the course of infection. This analysis revealed the temporally dynamic expression of a number of known and putative transcriptional regulators and virulence factors, providing insight into their role during infection. In addition, we identified several F. tularensis genes that are significantly up-regulated during infection but had not been previously identified as virulence factors. These unknown genes may make attractive therapeutic or vaccine targets.
土拉弗朗西斯菌是一种动物源细胞内病原体,能够导致潜在致命的人类感染。与所有成功的细菌病原体一样,土拉弗朗西斯菌在感染宿主细胞时,以及在细胞内遇到不同的微环境时,能够迅速对其环境变化做出反应。这种适应感染挑战的能力需要快速和全局的基因表达模式转变。在这项研究中,我们使用一种新颖的病原体转录物富集策略和全转录组测序(RNA-Seq)技术,详细描述了土拉弗朗西斯菌 LVS 在感染小鼠巨噬细胞时的快速和全局基因表达变化。我们在两个关键的感染阶段(吞噬体逃逸和细胞质复制)对所有细菌基因进行了差异基因表达分析。通过将感染过程中这两个阶段的土拉弗朗西斯菌转录组与在培养物中生长的细菌的转录组进行比较,我们能够鉴定出在感染过程中差异表达的基因集。该分析揭示了许多已知和假定的转录调节剂和毒力因子的时间动态表达,为它们在感染过程中的作用提供了深入了解。此外,我们还鉴定出了一些在感染过程中显著上调的土拉弗朗西斯菌基因,但以前并未被鉴定为毒力因子。这些未知基因可能成为有吸引力的治疗或疫苗靶点。